Repercussions of the Karonga prevention trial for tuberculosis control
Lancet
.
1996 Jul 6;348(9019):4.
doi: 10.1016/s0140-6736(05)64349-8.
Author
H L Rieder
1
Affiliation
1
International Union Against Tuberculosis and Lung Disease, Paris, France.
PMID:
8691932
DOI:
10.1016/s0140-6736(05)64349-8
No abstract available
MeSH terms
BCG Vaccine / adverse effects*
HIV Infections / complications
Humans
Malawi
Tuberculosis, Pulmonary / prevention & control*
Vaccination / adverse effects
Substances
BCG Vaccine